| Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids A Kugler, G Stuhler, P Walden, G Zöller, A Zobywalski, P Brossart, ... Nature medicine 6 (3), 332-336, 2000 | 1083 | 2000 |
| Exact prediction of a natural T cell epitope O Rötzschke, K Falk, S Stevanovic, G Jung, P Walden, HG Rammensee European journal of immunology 21 (11), 2891-2894, 1991 | 558 | 1991 |
| T-cell epitope mapping by flow cytometry F Kern, IP Surel, C Brock, B Freistedt, H Radtke, A Scheffold, R Blasczyk, ... Nature medicine 4 (8), 975-978, 1998 | 357 | 1998 |
| Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation F Momburg, V Ortiz-Navarrete, J Neefjes, E Goulmy, Y Van De Wal, ... Nature 360 (6400), 174-177, 1992 | 300 | 1992 |
| Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. K Udaka, KH Wiesmüller, S Kienle, G Jung, P Walden Journal of immunology (Baltimore, Md.: 1950) 157 (2), 670-678, 1996 | 253 | 1996 |
| Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma MA Hofmann, C Kors, H Audring, P Walden, W Sterry, U Trefzer Journal of immunotherapy 31 (5), 520-527, 2008 | 175 | 2008 |
| Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients DE Speiser, K Schwarz, P Baumgaertner, V Manolova, E Devevre, ... Journal of Immunotherapy 33 (8), 848-858, 2010 | 162 | 2010 |
| A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. K Udaka, TJ Tsomides, P Walden, N Fukusen, HN Eisen Proceedings of the National Academy of Sciences 90 (23), 11272-11276, 1993 | 156 | 1993 |
| Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma U Trefzer, G Weingart, Y Chen, G Herberth, K Adrian, H Winter, H Audring, ... International Journal of Cancer 85 (5), 618-626, 2000 | 154 | 2000 |
| Induction of regulatory T-lymphocyte responses by liposomes carrying major histocompatibility complex molecules and foreign antigen P Waiden, ZA Nagy, J Klein Nature 315 (6017), 327-329, 1985 | 125 | 1985 |
| Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines TH Scott-Taylor, R Pettengell, I Clarke, G Stuhler, MC La Barthe, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1500 (3), 265-279, 2000 | 123 | 2000 |
| Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes. PR Walden, HN Eisen Proceedings of the National Academy of Sciences 87 (22), 9015-9019, 1990 | 121 | 1990 |
| Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. K Udaka, KH Wiesmüller, S Kienle, G Jung, P Walden The Journal of experimental medicine 181 (6), 2097-2108, 1995 | 112 | 1995 |
| Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results U Trefzer, G Herberth, K Wohlan, A Milling, M Thiemann, T Sharav, ... Vaccine 23 (17-18), 2367-2373, 2005 | 109 | 2005 |
| An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries K Udaka, KH Wiesmüller, S Kienle, G Jung, H Tamamura, H Yamagishi, ... Immunogenetics 51, 816-828, 2000 | 104 | 2000 |
| Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer S Gross, P Walden Immunology letters 116 (1), 7-14, 2008 | 99 | 2008 |
| Genomic aberrations and survival in cutaneous T cell lymphomas TC Fischer, S Gellrich, JM Muche, T Sherev, H Audring, H Neitzel, ... Journal of investigative dermatology 122 (3), 579-586, 2004 | 96 | 2004 |
| Cognate peptide-induced destruction of CD8+ cytotoxic T lymphocytes is due to fratricide. MW Su, PR Walden, DB Golan, HN Eisen Journal of immunology (Baltimore, Md.: 1950) 151 (2), 658-667, 1993 | 90 | 1993 |
| Vaccination with hybrids of tumor and dendritic cells induces tumor‐specific T‐cell and clinical responses in melanoma stage III and IV patients U Trefzer, G Herberth, K Wohlan, A Milling, M Thiemann, T Sherev, ... International journal of cancer 110 (5), 730-740, 2004 | 89 | 2004 |
| Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor R Brock, KH Wiesmüller, G Jung, P Walden Proceedings of the National Academy of Sciences 93 (23), 13108-13113, 1996 | 89 | 1996 |
Dr. Renato B. BaleeiroPostdoctoral Researcher, Barts Cancer Institute, Queen Mary University of LondonVerified email at qmul.ac.uk
